Catalog name Description price
R-M1-8572 C18-ELP3(VPGVGVPGVGVPGVG) The sequence "C18-ELP3(VPGVGVPGVGVPGVG)" suggests a modified or tagged version of the ELP3 protein. The "C18" indicates that there is a cysteine residue at position 18 that has been modified or added to the protein. "ELP3" refers to the ELP3 gene, which likely encodes for the protein. "(VPGVGVPGVGVPGVG)" represents a sequence motif or modification within the protein, possibly indicating a repeated motif of valine (V), proline (P), and glycine (G). price>
R-M1-8668 N3-Angiopep-2 N3-Angiopep-2/N3 modified Angiopep-2 (TFFYGGSRGKRNNFKTEEYC)/N3-TFFYGGSRGKRNNFKTEEYC/Azide-TFFYGGSRGKRNNFKTEEYC/Azide modified Angiopep-2 (TFFYGGSRGKRNNFKTEEYC) refers to a modified version of the peptide Angiopep-2. Angiopep-2 is a peptide that has been identified as a ligand with the ability to target the low-density lipoprotein receptor-related protein 1 (LRP1) at the blood-brain barrier (BBB). The N3 modification is a chemical modification made to enhance the stability and uptake of the peptide.The N3-Angiopep-2 peptide has been utilized in drug delivery systems to target and facilitate the transport of therapeutic agents across the blood-brain barrier. This modification enables better penetration of the peptide across the BBB and improves the delivery of drugs to the central nervous system for the treatment of various neurological disorders. price>
R-M1-8687 SH-IFLLWQR Thiol modified IFLLWQR/Thiol modified Ile-Phe-Leu–Leu-Trp-Gln-Arg/Thiol-IFLLWQR(Ile-Phe-Leu–Leu-Trp-Gln-Arg,IF7)/SH-IFLLWQR(Ile-Phe-Leu–Leu-Trp-Gln-Arg,IF7) can be used for research on targeting tumor cells. price>
R-M1-8760 NapGFFY-E(Deferroamine)ALKRQGRTLYGFGG-CONH2 NapGFFY-E(Deferroamine)ALKRQGRTLYGFGG-CONH2 is a modified peptide with a specific combination of amino acids and ferroamine modifications. price>